Biomarin Pharmaceutical (BMRN) Receivables - Other (2010 - 2012)
Biomarin Pharmaceutical (BMRN) posted Receivables - Other of $9.0 million for Q3 2012, down 7.76% on a QoQ basis from $9.8 million in Q2 2012, and up 23.81% year-over-year from $7.3 million in Q4 2011.
Biomarin Pharmaceutical (BMRN) Receivables - Other (2010 - 2012) Analysis & Trends
Biomarin Pharmaceutical's Receivables - Other history runs 3 years deep, the most recent figure standing at $9.0 million for Q3 2012.
- Quarterly Receivables - Other rose 23.81% year-over-year to $9.0 million in Q3 2012, while the trailing twelve-month figure through Sep 2012 was $9.0 million (up 23.81% YoY) and the FY2011 annual result came in at $6.1 million, down 16.63% from the prior year.
- Receivables - Other was $9.0 million for Q3 2012 at Biomarin Pharmaceutical, down from $9.8 million in the prior quarter.
- Across five years, Receivables - Other topped out at $9.8 million in Q2 2012 and bottomed at $4.6 million in Q2 2011.
- A 3-year average of $7.3 million and a median of $7.3 million in 2011 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2011 — Receivables - Other decreased 16.63% — and 2012, when it surged 111.9%.
- Biomarin Pharmaceutical's Receivables - Other stood at $7.3 million in 2010, then dropped by 16.63% to $6.1 million in 2011, then jumped by 48.01% to $9.0 million in 2012.
- Business Quant data shows BMRN's Receivables - Other at $9.0 million in Q3 2012, $9.8 million in Q2 2012, and $6.8 million in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 9.02 Mn |
| Sep 30, 2012 | 9.02 Mn |
| Jun 30, 2012 | 9.78 Mn |
| Jun 30, 2012 | 9.78 Mn |
| Mar 31, 2012 | 6.83 Mn |
| Mar 31, 2012 | 6.83 Mn |
| Dec 31, 2011 | 6.09 Mn |
| Dec 31, 2011 | 6.09 Mn |
| Sep 30, 2011 | 7.28 Mn |
| Sep 30, 2011 | 7.28 Mn |
| Jun 30, 2011 | 4.61 Mn |
| Jun 30, 2011 | 4.61 Mn |
| Dec 31, 2010 | 7.31 Mn |
| Dec 31, 2010 | 7.31 Mn |